Acyl-CoA oxidase 1 (ACOX1) is an enzyme that in humans is encoded by the ACOX1 gene. This form of acyl-CoA oxidase is involved in breaking down straight chain very-long-chain fatty acids (VLCFAs) as part of peroxisomal beta-oxidation. It can act on both saturated and unsaturated VLCFAs.
The protein encoded by this gene is the first enzyme of the fatty acid beta-oxidation pathway, which catalyzes the desaturation of acyl-CoAs to 2-trans-enoyl-CoAs. It donates electrons directly to molecular oxygen, thereby producing hydrogen peroxide. Defects in this gene result in pseudoneonatal adrenoleukodystrophy, a disease that is characterized by accumulation of very long chain fatty acids. Alternatively spliced transcript variants encoding different isoforms have been identified.
Clinical features of ACOX1 deficiency generally include hypotonia and neonatal seizures.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.